NEW YORK (GenomeWeb News) – Integrated Media Holdings today said that its wholly owned subsidiary, Telechem International, has entered into an exclusive agreement with BioSystems International to make and sell microarrays featuring antibodies that identify proteins uniquely expressed in human plasma.
Under the pact, BSI will provide normal human plasma-profiling monoclonal antibodies. Telechem, which also operates under the name Arrayit, will use its microarray technology to print the antibodies onto glass slides. It also will market the Human Plasma Proteome Microarray through its existing network of worldwide marketing partners.
“This unique approach of using novel antibodies to detect human plasma proteins will speed the research and identification of biomarkers for early-stage disease diagnostics,” Telechem CEO Rene Schena said in a statement.
The partners expect the first microarrays from the collaboration to be available next quarter.